Patient & Survivor Care
Conference Coverage
NCCRT Confirmed as Best Approach in Locally Advanced, Resectable ESCC
Researchers compred neoadjuvant concurrent chemoradiotherapy with adjuvant sequential chemoradiotherapy (ASCRT) in locally advanced esophageal...
Feature
‘Cancer Doesn’t Wait’: How Prior Authorization Harms Care
Despite the large tumor, nestled in a sensitive area, a Boston-based radiation oncologist could envision a bright future for her patient.
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
News from the FDA/CDC
FDA Panel Votes for Limits on Gastric, Esophageal Cancer Immunotherapy
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted in favor of restricting the use of these immunotherapy agents to patients with PD-L1...
From the Journals
Minimal Risks With SBRT in Stage I NSCLC
Researchers explored toxicity and 90-day mortality outcomes in patients who received SBRT.
News from the FDA/CDC
FDA Okays Osimertinib After CRT in Locally Advanced, Unresectable NSCLC
The drug was approved for patients whose disease has not progressed during or after concurrent or sequential platinum-based chemoradiation therapy...
Feature
Dr. Rogers’ Neighborhood: Guinea Pigs and Groundbreaking Cancer Care
Ohio State leukemia researcher prioritizes patients’ quality of life -- with a little help from her pets.
From the Journals
Survival Outcomes in Hepatocellular Carcinoma Patients Show Improvement Over Time
Researchers conducted a retrospective cohort study to evaluate survival trends among 3441 patients with HCC.
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
From the Journals
Black Women Have a Higher Risk for Death in BC Subtypes
Researchers examined racial differences in BC survival by subtype through conducting a systematic review and meta-analysis of 18 US studies.